English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/10527
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

LC-based analysis of drugs of abuse and their metabolites in urine

AuthorsPizzolato, Tânia Mara; López de Alda, Miren; Barceló, Damià
KeywordsAnalysis
Cocaine
Drug of abuse
LC-MS2
Liquid chromatography
Mass spectrometry
Urine
Water
Issue Date24-Apr-2007
PublisherElsevier
CitationTrAC-Trends in Analytical Chemistry 26(6): 609-624 (2007)
AbstractIn the literature, many analytical methods have been described for the determination of illicit drugs in biological fluids. Urine is one of the preferred matrices for control of drugs of abuse because its analysis is considered non-invasive and the concentration of the compounds and their metabolites, as well as the volume of sample available, are higher than in other biological fluids. For the analysis of drugs of abuse in urine, liquid chromatography coupled to mass spectrometry (LC-MS) or tandem mass spectrometry (LCMS2) has become a powerful technique. Its main advantages are its selectivity and sensitivity, reduced need for sample preparation, absence of need for derivatization and reliability of results. In addition, when two selected reaction monitoring (SRM) transitions are recorded per compound, this technique provides the four identification points required by the European Union for identification and confirmation of illicit substances. For preconcentration or clean up of samples, specific procedures, such as those using mixed-mode solid phases, have allowed good recoveries and low limits of detection, and helped reduce ion suppression in LC-MS2. This review discusses methods published in 2000–2006 to determine the drugs of abuse consumed most (namely, amphetamines, methamphetamines, cannabinoids, cocaine, LSD and opiates) and their metabolites in urine, particularly by LC-MS2.
Description16 pages, 6 figures, 2 tables.-- Printed version published Jun 2007.-- Issue title: Pharmaceutical-residue analysis.
Publisher version (URL)http://dx.doi.org/10.1016/j.trac.2007.04.005
URIhttp://hdl.handle.net/10261/10527
DOI10.1016/j.trac.2007.04.005
ISSN0167-2940
Appears in Collections:(IDAEA) Artículos
Files in This Item:
There are no files associated with this item.
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.